According to Wshu, New York State Attorney General Letitia James has allocated over $16 million for Long Island to address what she referred to as the "teen vaping problem." The funding comes from a multi-state settlement agreement with e-cigarette manufacturer JUUL.
In terms of compensation distribution, New York State received over 1.12 billion dollars. This funding will be used for statewide public education initiatives, as well as school anti-e-cigarette programs.
The funding allocated to Long Island will be distributed to Nassau County and Suffolk County, as well as their BOCES centers.
James sued JUUL in 2019, alleging that their marketing tactics targeted at young people were deceptive. That year, the state saw its first death caused by an e-cigarette, a 17-year-old from the Bronx.
The age of smokers is getting younger, with even middle school students starting to smoke and use nicotine due to attractive marketing, enticing fruit flavors, flashy parties, and seemingly cool promises.
In an agreement reached last year, JUUL was found to have misled consumers about the nicotine content of its products and falsely claimed that its e-cigarettes were safer than traditional cigarettes.
Both big tech and big tobacco companies are using similar tactics to attract our children. They are getting them addicted to social media feeds and nicotine, encouraging them to indulge in scrolling and smoking. We have seen firsthand the significant harm this is causing to the mental and physical health of our children.
In addition, Connecticut will receive approximately $16 million in compensation from the settlement.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
